miRNA Details
miRNA General Information | |||||
---|---|---|---|---|---|
miRNA Mature ID | hsa-miR-203a-3p | ||||
miRNA Stemloop AC | MI0000283 | ||||
miRNA Stemloop ID | hsa-mir-203 | ||||
Sequence | gugaaauguuuaggaccacuag | ||||
miRNA General Information | |||||
miRNA Mature ID | hsa-miR-203a-3p | ||||
miRNA Stemloop AC | MI0000283 | ||||
miRNA Stemloop ID | hsa-mir-203a | ||||
Sequence | gugaaauguuuaggaccacuag | ||||
TTD Target(s) Regulated by This miRNA | Matrix metalloproteinase-1 (MMP-1) | Successful Target | Target Info | [1] | |
Proto-oncogene c-Src (SRC) | Successful Target | Target Info | [2] | ||
Tyrosine-protein kinase ABL1 (ABL) | Successful Target | Target Info | [3] | ||
Cyclin-dependent kinase 6 (CDK6) | Successful Target | Target Info | [4] | ||
PI3-kinase alpha (PIK3CA) | Successful Target | Target Info | [5] | ||
Interleukin-6 (IL6) | Successful Target | Target Info | [1] | ||
Interleukin-8 (IL8) | Successful Target | Target Info | [6] | ||
Protein kinase C alpha (PRKCA) | Successful Target | Target Info | [7] | ||
Tumor necrosis factor (TNF) | Successful Target | Target Info | [8] | ||
Endothelin A receptor (EDNRA) | Successful Target | Target Info | [9] | ||
Fibroblast growth factor-2 (FGF2) | Successful Target | Target Info | [10] | ||
Vascular endothelial growth factor A (VEGFA) | Successful Target | Target Info | [11] | ||
Apoptosis inhibitor survivin (BIRC5) | Clinical trial Target | Target Info | [12] | ||
Apoptosis regulator Bcl-W (BCL-W) | Clinical trial Target | Target Info | [13] | ||
ATM serine/threonine kinase (ATM) | Clinical trial Target | Target Info | [14] | ||
Interleukin-24 (IL24) | Clinical trial Target | Target Info | [8] | ||
Leukemia inhibitory factor receptor (LIFR) | Clinical trial Target | Target Info | [15] | ||
E2F transcription factor 1 (E2F1) | Clinical trial Target | Target Info | [16] | ||
Phospholipase D2 (PLD2) | Clinical trial Target | Target Info | [17] | ||
Arachidonate 15-lipoxygenase (15-LOX) | Patented-recorded Target | Target Info | [18] | ||
Signal transducer and activator of transcription 1 (STAT1) | Patented-recorded Target | Target Info | [19] | ||
NF-kappa-B-activating kinase (TBK1) | Patented-recorded Target | Target Info | [20] | ||
Myeloid differentiation primary response protein MyD88 (MYD88) | Literature-reported Target | Target Info | [21] | ||
Transcription factor AP-1 (JUN) | Discontinued Target | Target Info | [22] | ||
RAC-beta serine/threonine-protein kinase (AKT2) | Literature-reported Target | Target Info | [23] | ||
Matrix metalloproteinase-10 (MMP-10) | Patented-recorded Target | Target Info | [16] | ||
Thymidylate synthase (TYMS) | Clinical trial Target | Target Info | [24] | ||
Cyclic AMP-responsive element-binding protein (CREB1) | Literature-reported Target | Target Info | [25] | ||
Polycomb complex protein BMI-1 (BMI1) | Clinical trial Target | Target Info | [26] | ||
Protein phosphatase 1D (PPM1D) | Literature-reported Target | Target Info | [27] | ||
Caveolin 1 (CAV1) | Literature-reported Target | Target Info | [28] | ||
Epithelial cadherin (CDH1) | Literature-reported Target | Target Info | [29] | ||
GAP-associated tyrosine phosphoprotein p62 (KHDRBS1) | Literature-reported Target | Target Info | [30] | ||
Ras-related protein Rab-22A (Rab22a) | Literature-reported Target | Target Info | [31] | ||
Zinc finger E-box-binding homeobox 2 (ZEB2) | Literature-reported Target | Target Info | [16] | ||
Runt-related transcription factor 2 (RUNX2) | Literature-reported Target | Target Info | [32] | ||
Suppressor of cytokine signaling 3 (SOCS3) | Literature-reported Target | Target Info | [33] | ||
Protein(s) Regulated by This miRNA | Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 1 | Regulated Protein | [34] | ||
ATP-binding cassette sub-family E member 1 | Regulated Protein | [4] | |||
Barrier-to-autointegration factor | Regulated Protein | [36] | |||
E3 ubiquitin-protein ligase Hakai | Regulated Protein | [37] | |||
Eyes absent homolog 4 | Regulated Protein | [9] | |||
Frizzled-2 | Regulated Protein | [39] | |||
Ganglioside-induced differentiation-associated protein 1 | Regulated Protein | [9] | |||
GTP-binding nuclear protein Ran | Regulated Protein | [40] | |||
Homeobox protein DLX-5 | Regulated Protein | [16] | |||
Homeobox protein Hox-D3 | Regulated Protein | [42] | |||
Kinesin-1 heavy chain | Regulated Protein | [43] | |||
Kinesin-like protein KIF2A | Regulated Protein | [43] | |||
LIM and SH3 domain protein 1 | Regulated Protein | [44] | |||
Mothers against decapentaplegic homolog 4 | Regulated Protein | [16] | |||
Nuclear receptor subfamily 2 group C member 2 | Regulated Protein | [45] | |||
Peripheral plasma membrane protein CASK | Regulated Protein | [46] | |||
Protein lin-28 homolog B | Regulated Protein | [47] | |||
Ras-associated and pleckstrin homology domains-containing protein 1 | Regulated Protein | [40] | |||
Ras-related protein Rap-1A | Regulated Protein | [48] | |||
Suppressor of cytokine signaling 6 | Regulated Protein | [8] | |||
Tight junction protein ZO-2 | Regulated Protein | [50] | |||
Transcription factor 4 | Regulated Protein | [51] | |||
Tumor protein 63 | Regulated Protein | [52] | |||
UV radiation resistance-associated gene protein | Regulated Protein | [28] | |||
Wnt inhibitory factor 1 | Regulated Protein | [54] | |||
Zinc finger protein 148 | Regulated Protein | [55] | |||
Zinc finger protein SNAI1 | Regulated Protein | [56] | |||
Zinc finger protein SNAI2 | Regulated Protein | [57] | |||
References | |||||
REF 1 | Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011 Feb;63(2):373-81. | ||||
REF 2 | ING1b-inducible microRNA203 inhibits cell proliferation. Br J Cancer. 2013 Mar 19;108(5):1143-8. | ||||
REF 3 | Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell. 2008 Jun;13(6):496-506. | ||||
REF 4 | miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010 May;31(5):766-76. | ||||
REF 5 | MicroRNA-203 accelerates apoptosis in LPS-stimulated alveolar epithelial cells by targeting PIK3CA. Biochem Biophys Res Commun. 2014 Aug 8;450(4):1297-303. | ||||
REF 6 | MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling. Mol Cancer Ther. 2015 Nov;14(11):2653-64. | ||||
REF 7 | miR-203 inhibits cell proliferation and migration of lung cancer cells by targeting PKC. PLoS One. 2013 Sep 10;8(9):e73985. | ||||
REF 8 | Regulation of pro-inflammatory cytokines TNF and IL24 by microRNA-203 in primary keratinocytes. Cytokine. 2012 Dec;60(3):741-8. | ||||
REF 9 | A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol. 2011 Jan;131(1):20-9. | ||||
REF 10 | miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2. Diagn Pathol. 2015 Apr 9;10:24. | ||||
REF 11 | miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer. Cell Physiol Biochem. 2013;32(1):64-73. | ||||
REF 12 | MicroRNA-203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells. J Exp Clin Cancer Res. 2012 Jun 19;31:58. | ||||
REF 13 | microRNA-203 suppresses bladder cancer development by repressing bcl-w expression. FEBS J. 2011 Mar;278(5):786-92. | ||||
REF 14 | Viral microRNA targetome of KSHV-infected primary effusion lymphoma cell lines. Cell Host Microbe. 2011 Nov 17;10(5):515-26. | ||||
REF 15 | miR-203, a tumor suppressor frequently down-regulated by promoter hypermethylation in rhabdomyosarcoma. J Biol Chem. 2014 Jan 3;289(1):529-39. | ||||
REF 16 | Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res. 2011 Aug 15;17(16):5287-98. | ||||
REF 17 | MicroRNA-203 inhibits the proliferation and invasion of U251 glioblastoma cells by directly targeting PLD2. Mol Med Rep. 2014 Feb;9(2):503-8. | ||||
REF 18 | MicroRNA profiling in mucosal biopsies of eosinophilic esophagitis patients pre and post treatment with steroids and relationship with mRNA targets. PLoS One. 2012;7(7):e40676. | ||||
REF 19 | MiRNA203 suppresses the expression of protumorigenic STAT1 in glioblastoma to inhibit tumorigenesis. Oncotarget. 2016 Dec 20;7(51):84017-84029. | ||||
REF 20 | MiR-203 Determines Poor Outcome and Suppresses Tumor Growth by Targeting TBK1 in Osteosarcoma. Cell Physiol Biochem. 2015;37(5):1956-66. | ||||
REF 21 | MyD88 as a target of microRNA-203 in regulation of lipopolysaccharide or Bacille Calmette-Guerin induced inflammatory response of macrophage RAW264.7 cells. Mol Immunol. 2013 Oct;55(3-4):303-9. | ||||
REF 22 | MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. Oncogenesis. 2012 Mar 12;1:e3. | ||||
REF 23 | miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Cancer Lett. 2011 May 1;304(1):52-9. | ||||
REF 24 | miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer. Oncol Rep. 2015 Feb;33(2):607-14. | ||||
REF 25 | Epigenetic silencing of MIR203 in multiple myeloma. Br J Haematol. 2011 Sep;154(5):569-78. | ||||
REF 26 | Coordinated regulation of polycomb group complexes through microRNAs in cancer. Cancer Cell. 2011 Aug 16;20(2):187-99. | ||||
REF 27 | Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res. 2010 Sep 15;70(18):7176-86. | ||||
REF 28 | MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle. 2012 Apr 1;11(7):1291-5. | ||||
REF 29 | microRNA-203 suppresses invasion of gastric cancer cells by targeting ERK1/2/Slug/ E-cadherin signaling. Cancer Biomark. 2017;19(1):11-20. | ||||
REF 30 | MicroRNA-203 inhibits the malignant progression of neuroblastoma by targeting Sam68. Mol Med Rep. 2015 Oct;12(4):5554-60. | ||||
REF 31 | miR-203 Acts as a Tumor Suppressor Gene in Osteosarcoma by Regulating RAB22A. PLoS One. 2015 Sep 18;10(9):e0132225. | ||||
REF 32 | Targeting of Runx2 by miR-135 and miR-203 Impairs Progression of Breast Cancer and Metastatic Bone Disease. Cancer Res. 2015 Apr 1;75(7):1433-44. | ||||
REF 33 | MicroRNAs: novel regulators involved in the pathogenesis of psoriasis PLoS One. 2007 Jul 11;2(7):e610. | ||||
REF 34 | MiR-203 is downregulated in laryngeal squamous cell carcinoma and can suppress proliferation and induce apoptosis of tumours.Tumour Biol. 2014 Jun;35(6):5953-63. | ||||
REF 35 | miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis. 2010 May;31(5):766-76. | ||||
REF 36 | BANF1 is downregulated by IRF1-regulated microRNA-203 in cervical cancer.PLoS One. 2015 Feb 6;10(2):e0117035. | ||||
REF 37 | miR-203 regulates cell proliferation through its influence on Hakai expression.PLoS One. 2012;7(12):e52568. | ||||
REF 38 | A comprehensive analysis of microRNA expression during human keratinocyte differentiation in vitro and in vivo. J Invest Dermatol. 2011 Jan;131(1):20-9. | ||||
REF 39 | miR-203 Inhibits Frizzled-2 Expression via CD82/KAI1 Expression in Human Lung Carcinoma Cells.PLoS One. 2015 Jul 1;10(7):e0131350. | ||||
REF 40 | MicroRNA-203 contributes to skin re-epithelialization.Cell Death Dis. 2012 Nov 29;3:e435. | ||||
REF 41 | Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Clin Cancer Res. 2011 Aug 15;17(16):5287-98. | ||||
REF 42 | EGR1 mediates miR-203a suppress the hepatocellular carcinoma cells progression by targeting HOXD3 through EGFR signaling pathway.Oncotarget. 2016 Jul 19;7(29):45302-45316. | ||||
REF 43 | MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b.J Invest Dermatol. 2014 Feb;134(2):461-469. | ||||
REF 44 | miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1.Int J Oncol. 2012 Nov;41(5):1653-61. | ||||
REF 45 | Ectopic expressed miR-203 contributes to chronic obstructive pulmonary disease via targeting TAK1 and PIK3CA. Int J Clin Exp Pathol. 2015 Sep 1;8(9):10662-70. | ||||
REF 46 | Down-regulation of miR-203 induced by Helicobacter pylori infection promotes the proliferation and invasion of gastric cancer by targeting CASK.Oncotarget. 2014 Nov 30;5(22):11631-40. | ||||
REF 47 | miR-203 enhances let-7 biogenesis by targeting LIN28B to suppress tumor growth in lung cancer.Sci Rep. 2017 Feb 20;7:42680. | ||||
REF 48 | miR-203a is involved in HBx-induced inflammation by targeting Rap1a.Exp Cell Res. 2016 Nov 15;349(1):191-197. | ||||
REF 49 | Regulation of pro-inflammatory cytokines TNF and IL24 by microRNA-203 in primary keratinocytes. Cytokine. 2012 Dec;60(3):741-8. | ||||
REF 50 | Identification of specific miRNAs targeting proteins of the apical junctional complex that simulate the probiotic effect of E. coli Nissle 1917 on T84 epithelial cells.Int J Biochem Cell Biol. 2012 Feb;44(2):341-9. | ||||
REF 51 | Comparative effects of diet and carcinogen on microRNA expression in the stem cell niche of the mouse colonic crypt. Biochim Biophys Acta. 2016 Jan;1862(1):121-34. | ||||
REF 52 | A skin microRNA promotes differentiation by repressing 'stemness'.Nature. 2008 Mar 13;452(7184):225-9. | ||||
REF 53 | MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction. Cell Cycle. 2012 Apr 1;11(7):1291-5. | ||||
REF 54 | Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.Oncogene. 2015 Aug 20;34(34):4519-30. | ||||
REF 55 | Anti-oncogenic microRNA-203 induces senescence by targeting E2F3 protein in human melanoma cells.J Biol Chem. 2012 Apr 6;287(15):11769-77. | ||||
REF 56 | Signaling between transforming growth factor (TGF-) and transcription factor SNAI2 represses expression of microRNA miR-203 to promote epithelial-mesenchymal transition and tumor metastasis.J Biol Chem. 2013 Apr 12;288(15):10241-53. | ||||
REF 57 | MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells.Int J Cancer. 2013 Aug 1;133(3):544-55. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.